Preclinical development of novel first-in-class epitranscriptomic drug candidates against neurological and neuropsychiatric diseases
Added: Apr 23, 2025
B470
medicine
health
Abstract
This project is about characterization of acute and chronic in vivo effects of novel epitranscriptome-targeting drug candidates in animal models of neuropsychiatric disorders, by use of traditional drug screening tests and innovative models of affective states. The objectove of this project is making efficacy-based recommendations in the selection of drug candidates for eventual clinical investigation.
Related Papers
Safety and quality of high-risk plant-based foods and meat alternatives
Roasto, Mati
Similarity: 0.80
Apr 23, 2025
The Circular Schools – Empowering Secondary Education Students for a Green Future through Circularity Thinking Strategies
Voronova, Viktoria
Similarity: 0.80
Apr 23, 2025
Developing Estonian startup ecosystem and startup incubation programs: Part 1 - Developing the deep-tech startup ecosystem.
Lööve, Triinu
Similarity: 0.80
Apr 23, 2025